Enterprise Performance, R & D Expense Ratio and the Total Factor Productivity of TCM Listed Enterprises-- Empirical Research in the Context of New Quality Productivity
This study, focusing on the high-quality development of traditional Chinese medicine (TCM) enterprises, examines A-share listed TCM companies from 2018 to 2022. It uncovers that operational performance positively influences total factor productivity, with R&D expenses exerting a negative intermediary effect. This impact is more pronounced in smaller firms. Enhancing operational performance is thereby crucial for the successful transformation and high-quality growth of TCM enterprises.
Authors
- Li Dong (ORCID: https://orcid.org/0000-0002-3213-7971)
- Lei Luo (ORCID: https://orcid.org/0000-0002-7008-4276)
- Hui Li (ORCID: https://orcid.org/0000-0002-3885-6125)
- Zhebing Hu
Publication Details
- Journal
- Modern economic management forum.
- Published
- 2024-09-02
- DOI
- https://doi.org/10.18686/memf.v2i3.4533
- Primary Topic
- Working Capital and Financial Performance
- Type
- article
- Field-Weighted Citation Impact
- 0.00